Epidural Anesthesia for Caesarean Section in a Patient with Risk of Malignant Hyperthermia

1. Jukic M, Husedžinovic I, Kvolik S, Majeric K.V, Peric M & Žunic J. (2013). Klinicka anesteziologija (2nd ed). Zagreb, Medicinska naklada.Search in Google Scholar

2. Rosenberg H, Pollock N, Schiemann A, Bulger T. & Stowell K. (2015). Malignant hyperthermia: a review. Orphanet J Rare Dis. 10:93. DOI: 10.1186/s13023-015-0310-1.10.1186/s13023-015-0310-1452436826238698Search in Google Scholar

3. Kollmann-Carnaiora A, Alsina E, Dominouez A, Del Blanco B, Yepes MJ, Guerrero JL. & Garcia A. (2017). Clinical protocol for the management hyperthermia. Rev Esp Anestesiol Reanim. 64(1):32-40. DOI: 10.1016/j.redar.2016.06.004.10.1016/j.redar.2016.06.00427633384Open DOISearch in Google Scholar

4. Metteriein T, Schuster F, Graf BM. & Anetseder M. (2014). Malignant hyperthermia. Anaesthesist. 63(12):908-18. DOI: 10.1007/s00101-014-2392-x.10.1007/s00101-014-2392-x25384957Open DOISearch in Google Scholar

5. Harison GG, Isaacs H. (1992). Malignant hyperthermia. An historical vignette. Anaesthesia. 47(1):54-6.Search in Google Scholar

6. Lalevic P, (1999). Anesteziologija. (1st ed). Beograd. Zavod za udžbenike i nastavna sredstva.Search in Google Scholar

7. Ording H. (1985). Incidence of malignant hyperthermia in Denmark. Anesth. Analg. 64(7):700-4.4014731Search in Google Scholar

8. Ibarra MC, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, et al. (2006). Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology. 104(6):1146-54.Search in Google Scholar

9. Butterworth FJ, Mackey CD. & Wasnick DJ. (2013). Morgan and Mikhails Clinical Anesthesiology. (5th ed). New York. Mc Graw Hill Education.Search in Google Scholar

10. Miller, Ronald D. (1994). Anesthesia. (4th ed). New York. Churchill LivingstoneSearch in Google Scholar

11. Osada H, Masuda K, Seki K, Sekiva S. (2004). Multiminicore disease with susceptibility to malignant hiperthermia in pregnanci. Ginecol Obstet Invest. 58(1):32-5.Search in Google Scholar

12. Lucy SJ. (1994). Anesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient. Can J Anaesth. 41(12):1220-6.Search in Google Scholar

13. Bilmen JG, Gillies RI. (2014). Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients. Anaesth Intenzive Care. 42(1):51-8.Search in Google Scholar

14. Rosaeg OP, Morrison S, MacLeod JP. (1996). Anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Can J Anaesth. 43(4):403-7.10.1007/BF030117228697558Open DOISearch in Google Scholar

15. Foster RN, Boothroyd KP. (2008). Caesarean section in a complicated case of central core disease. Anaesthesia, Journal of Association of Anasethetists of Great Britain and Ireland. 63: 544-7. DOI: 10.1111/j.1365-2044.2007.05411.x10.1111/j.1365-2044.2007.05411.x18412656Open DOISearch in Google Scholar

16. Goto S, Ogata K, Fujie T, Fujigaki T, Nakamura H, Yukinari T & Shibata O. (1993). Caesarean section in a patient with past history of fulminant malignant hyperthermia. Masui. 42(2):271-5.Search in Google Scholar

17. Malignant Hyperthermia Association of the USA-FAQS Molecular Genetics http://www.mhaus.org/faqs/molecular-genetics. Accessed 10 July 2015.Search in Google Scholar

18. European Malignant Hyperthermia Group http://www.emhg.org. Accessed 10 July 2015.Search in Google Scholar